CVS Group plc
CVS Group plc Fundamental Analysis
CVS Group plc (CVSGF) shows weak financial fundamentals with a PE ratio of 38.79, profit margin of 2.46%, and ROE of 7.76%. The company generates $0.9B in annual revenue with moderate year-over-year growth of 4.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 28.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze CVSGF's fundamental strength across five key dimensions:
Efficiency Score
WeakCVSGF struggles to generate sufficient returns from assets.
Valuation Score
ModerateCVSGF shows balanced valuation metrics.
Growth Score
WeakCVSGF faces weak or negative growth trends.
Financial Health Score
ModerateCVSGF shows balanced financial health with some risks.
Profitability Score
WeakCVSGF struggles to sustain strong margins.
Key Financial Metrics
Is CVSGF Expensive or Cheap?
P/E Ratio
CVSGF trades at 38.79 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, CVSGF's PEG of -3.17 indicates potential undervaluation.
Price to Book
The market values CVS Group plc at 3.04 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 3.05 times EBITDA. This is generally considered low.
How Well Does CVSGF Make Money?
Net Profit Margin
For every $100 in sales, CVS Group plc keeps $2.46 as profit after all expenses.
Operating Margin
Core operations generate 11.42 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.76 in profit for every $100 of shareholder equity.
ROA
CVS Group plc generates $3.22 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
CVS Group plc produces operating cash flow of $96.60M, showing steady but balanced cash generation.
Free Cash Flow
CVS Group plc produces free cash flow of $67.34M, offering steady but limited capital for shareholder returns and expansion.
FCF Per Share
Each share generates $0.96 in free cash annually.
FCF Yield
CVSGF converts 7.84% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
38.79
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-3.17
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.04
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.93
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.22
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.07
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How CVSGF Stacks Against Its Sector Peers
| Metric | CVSGF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 38.79 | 23.78 | Worse (Expensive) |
| ROE | 7.76% | 1098.00% | Weak |
| Net Margin | 2.46% | -626.00% (disorted) | Weak |
| Debt/Equity | 1.22 | 0.86 | Weak (High Leverage) |
| Current Ratio | 1.07 | 2.64 | Neutral |
| ROA | 3.22% | -8081.00% (disorted) | Weak |
CVSGF outperforms its industry in 0 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews CVS Group plc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
54.98%
Industry Style: Cyclical, Growth, Discretionary
High GrowthEPS CAGR
233.47%
Industry Style: Cyclical, Growth, Discretionary
High GrowthFCF CAGR
4.20%
Industry Style: Cyclical, Growth, Discretionary
Growing